| USD millions | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM | Trend | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Cost of revenue | 0.3 | 0.0 | 0.0 | 0.0 | 0.2 | 0.2 | 0.2 | −0.9% | |
| Gross profit | (0.3) | 0.0 | 0.0 | 0.0 | (0.2) | (0.2) | (0.2) | +0.9% | |
| Research & development | 6.9 | 24.0 | 30.1 | 15.8 | 22.8 | 23.0 | — | — | |
| Selling, general & administrative | 7.6 | 9.1 | 10.7 | 11.4 | 16.3 | 31.9 | — | — | |
| Selling & marketing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | |
| Operating expenses | 14.5 | 33.1 | 40.8 | 27.3 | 38.8 | 54.7 | 58.2 | +6.5% | |
| Operating income | (14.8) | (33.1) | (40.8) | (27.3) | (39.1) | (54.9) | (58.3) | −6.2% | |
| Interest expense | 0.0 | 0.0 | 1.8 | 2.9 | 2.2 | 0.8 | 1.0 | +21.4% | |
| Interest income | 0.1 | 0.0 | 0.2 | 0.8 | 2.4 | 1.5 | 2.8 | +84.2% | |
| Other income / expense | 0.0 | (0.1) | (1.6) | (2.6) | (0.8) | 0.2 | — | — | |
| Pre-tax income | (14.7) | (33.2) | (42.4) | (29.8) | (39.8) | (54.6) | (114.0) | −108.7% | |
| Income tax | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Net income | (14.7) | (33.2) | (42.4) | (29.8) | (39.8) | (54.6) | (114.0) | −108.7% | |
| Discontinued operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | |
| Other net income adjustments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | |
| EPS, basic (per share) | (5.39) | (4.05) | (3.95) | (1.50) | (1.24) | (1.25) | (1.55) | −23.6% | |
| EPS, diluted (per share) | (5.39) | (4.05) | (3.95) | (1.50) | (1.24) | (1.25) | (1.55) | −23.6% | |
| EBITDA | (14.5) | (32.9) | (40.3) | (26.7) | (37.4) | (53.6) | (57.5) | −7.2% | |
| Depreciation & amortization | 0.3 | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | −0.9% | |
| Weighted average shares (shares) | 2,718,909 | 8,119,835 | 10,593,034 | 19,827,354 | 32,071,146 | 43,594,652 | — | — | |
| Weighted average diluted shares (shares) | 2,718,909 | 8,119,835 | 10,593,034 | 19,827,354 | 32,071,146 | 43,594,652 | — | — |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
TTM ends 2026-06-30 and uses four consecutive reported quarters.
